Most people find that the injection process quickly becomes part of their routine
The GLP-1 Super Responder Playbook Turn GLP-1 Results into Lasting Transformation GLP-1 medications can help people lose weight, but not everyone gets the same results, and not everyone keeps it
Aids in appetite control
In a clinical trial published in the New England Journal of Medicine last year, people who were overweight or obese, but did not have diabetes, lost an average of 52 pounds on the highest dose of the drug, or more than 20% of their starting weight
Semaglutide ( Ozempic, Wegovy, Rybelsus ) and Tirzepatide ( Mounjaro and Zepbound ) are available throughout the US, many European countries, moving into new markets in China, India, Brazil and Mexico